<DOC>
	<DOC>NCT00595270</DOC>
	<brief_summary>The study investigates the long term persistence the Japanese encephalitis vaccine IC51 and the need of a booster dose</brief_summary>
	<brief_title>Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51</brief_title>
	<detailed_description>This is an open label, non‐randomized multi‐center phase 3 follow‐up study. All volunteers having completed trial IC51‐304 (NCT00595790) will be enrolled into this trial at 2 sites</detailed_description>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis, Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>At least 18 years of age Written informed consent obtained prior to study entry Subjects correctly included in and having completed study IC51304 according to the protocol. Use of any other investigational or nonregistered drug or vaccine in addition to the study vaccine during the study period Immunodeficiency including postorgantransplantation or immunosuppressive therapy Pregnancy, lactation or unreliable contraception in female subjects</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>